TrialClinical and vaccine immunology : CVI2008

Clinical phase 1 testing of the safety and immunogenicity of an epitope-based DNA vaccine in human immunodeficiency virus type 1-infected subjects receiving highly active antiretroviral therapy.

Cara C Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.